Advancing gene-editing platforms to improve the viability of rare-disease therapeutics: key insights from a 2024 Scientific Exchange hosted by ARM, ISCT, and Danaher
推进基因编辑平台以提高罕见病疗法的可行性:由ARM、ISCT和丹纳赫公司联合主办的2024年科学交流会的主要见解
期刊:Cytotherapy
影响因子:3.2
doi:10.1016/j.jcyt.2025.06.010
Urnov, Fyodor; Kassim, Sadik; Musunuru, Kiran; Liu, David; Lee, Ann; Barrera, Luis; Stetkiewicz, Pam; Bruno, Julianne; Hewitt, Matthew; Lister, Troy; Malech, Harry; Gasch, Lindsay; Diver, Matt; Gertler, Nicholas; Grignon, Felix; Le, Audrey; Lehmicke, Michael; Almendro-Navarro, Vanessa; Lembong, Josephine